Latest News
Medtronic plans to SPR Therapeutics for USD650m to expand pain management portfolio
20 May 2026 - Healthcare technology company Medtronic plc (NYSE: MDT) announced on Wednesday that it intends to acquire privately held SPR Therapeutics Inc for approximately USD650m in cash, expanding its neuromodulation and chronic pain treatment po...
Implantica submits final FDA response for RefluxStop PMA application
20 May 2026 - Medical technology company Implantica AG (Nasdaq First North Premier Growth Market: IMP A SDB) announced on Wednesday that it has submitted its final response to the US Food and Drug Administration (FDA) regarding Module 3 of the Premar...
4basebio secures clinical supply agreement for Phase II immunotherapy trial
20 May 2026 - Cambridge-based biotechnology company 4basebio PLC (AIM: 4BB) disclosed on Wednesday that it has signed a Clinical Supply Agreement with an unnamed cancer immunotherapy developer to provide GMP-grade opDNA starting material for a Phase ...
FDA approves MEKanistic Therapeutics' IND for MTX-531
20 May 2026 - Biotechnology company MEKanistic Therapeutics announced on Tuesday that the US Food and Drug Administration (FDA) has cleared the Investigational New Drug application for MTX-531, its lead oncology candidate.Subject to standard start-up...
Sino Biological launches XPressMAX Cell-Free Protein Synthesis Kit
20 May 2026 - Recombinant technology specialist Sino Biological Inc (SZ:301047) announced on Tuesday the launch of its XPressMAX Cell-Free Protein Synthesis Kit (Cat#: CFKIT02), designed to supercharge artificial intelligence (AI)-driven high-through...